| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |